Could a gentle suction device ease lymphedema?
NCT ID NCT03760744
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether adding a device that applies gentle suction (negative pressure) to standard lymphedema therapy helps reduce arm swelling in women who developed lymphedema after cancer treatment. Eighteen participants received both standard therapy and the combined approach in a crossover design. The goal was to see if the combination improved fluid removal and quality of life more than standard care alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Complete decongestive therapy with or without negative pressure (LymphaTouch)
What this could lead to
If successful, this approach could offer a more effective way to manage lymphedema after cancer treatment, reducing swelling and improving daily function.
What could go wrong
This is a small, early-stage study with only 18 participants, so results may not apply to everyone. The added benefit of negative pressure over standard therapy alone is uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SECONDARY LYMPHEDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States